Genmab holds extraordinary general meeting

PUBT · 2d ago
Genmab holds extraordinary general meeting
  • Genmab held an extraordinary general meeting on Oct. 7, 2026.
  • Shareholders adopted the board’s 2026 board remuneration proposal, including share-based pay via restricted stock units.
  • The resolution triggered grants of 5,300 restricted stock units to board members under the remuneration policy.
  • Each unit carries a conditional right to one Genmab share, valued at DKK 2,487 per unit at grant.
  • The units are scheduled to vest after three years, on the first banking day of the following month.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genmab A/S published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610071217OMX_____CNEWS_EN_GNW1001276816_en) on October 07, 2026, and is solely responsible for the information contained therein.